DURECT Corp (NASDAQ:DRRX)
| 6.10 Delayed Data As of 3:59pm ET |  +0.30 / +5.17%Today’s Change | 3.17 Today|||52-Week Range 9.70 | +76.30% Year-to-Date |
Latest DRRX News | Press Releases
No recent news for DURECT Corp.
Today’s Trading
| Previous close | 5.80 |
| Today’s open | 5.79 |
| Day’s range | 5.60 - 6.33 |
| Volume | 2,689 |
| Average volume (3 months) | 53,819 |
| Market cap | $145.6M |
Data as of 3:59pm ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | -139.36% |
| Earnings growth (this year) | +31.67% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -53.58% |
| P/E ratio | NM |
| Price/Sales | 15.87 |
| Price/Book | 2.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SLGLSol Gel Technologies... | -0.21 | -4.12% |
| ---- | ||
| PRPHProphase Labs Inc | +0.27 | +3.42% |
| CLLSCellectis SA | -0.13 | -5.20% |
Data as of 3:59pm ET, 02/07/2023
Financials
| Next reporting date | March 8, 2023 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $14.0M |
| Annual profit (last year) | -$36.3M |
| Net profit margin | -259.46% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cupertino, California |
Forecasts
